These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 33306980)
21. Problematic Covid-19 vaccine trials in times of vaccine nationalism. Ravinetto R Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359 [TBL] [Abstract][Full Text] [Related]
22. "No" to placebo-controlled trials of Covid-19 vaccines. Ahmad A; Dhrolia MF Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356 [TBL] [Abstract][Full Text] [Related]
23. COVID-19 vaccine trials must include helminth-infected cohorts. Egwang TG; Owalla TJ; Kemigisha M Nat Immunol; 2022 Feb; 23(2):148. PubMed ID: 35075281 [No Abstract] [Full Text] [Related]
24. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum. Vashishtha VM; Kumar P Indian J Med Ethics; 2021; VI(1):1-3. PubMed ID: 34080991 [TBL] [Abstract][Full Text] [Related]
25. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning? Jhaveri R Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547 [TBL] [Abstract][Full Text] [Related]
26. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
27. Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective. Funk CD; Laferrière C; Ardakani A Viruses; 2021 Mar; 13(3):. PubMed ID: 33807839 [TBL] [Abstract][Full Text] [Related]
28. Vaccine-induced protection in aging adults and pandemic response. Schenkelberg T Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845 [No Abstract] [Full Text] [Related]
29. An immunologist's perspective on anti-COVID-19 vaccines. Milota T; Strizova Z; Smetanova J; Sediva A Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):545-552. PubMed ID: 34545040 [TBL] [Abstract][Full Text] [Related]
30. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19. Li Q; Wang J; Tang Y; Lu H Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059 [TBL] [Abstract][Full Text] [Related]
31. The long road. Cohen J Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838 [No Abstract] [Full Text] [Related]
33. Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants. Su S; Shao Y; Jiang S Emerg Microbes Infect; 2021 Dec; 10(1):439-441. PubMed ID: 33635184 [No Abstract] [Full Text] [Related]